BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 728922)

  • 1. [Inhibitive effect of serum from patients with cell immunity disorders on the formation of E-rosettes (authors transl)].
    Krc I; Matousková I; Krcová V
    Cas Lek Cesk; 1978; 117(44-45):1380-2. PubMed ID: 728922
    [No Abstract]   [Full Text] [Related]  

  • 2. E rosettes in lymphoproliferative diseases.
    Benesová E; Hermanský F; Sálková J
    Neoplasma; 1976; 23(1):23-30. PubMed ID: 1083961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.
    Opat P; Kolár V; Lauerová L; Pintera J; Zemanová D
    Neoplasma; 1980; 27(3):301-6. PubMed ID: 7453850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of levamisole on the formation of lymphocyte rosettes in patients undergoing surgery. Clinical study].
    Di Perri T; Auteri A; Laghi Pasini F; Ciani D; Bilenchi R; Pasqui AL; De Mauro D
    Recenti Prog Med; 1981 Nov; 71(5):515-31. PubMed ID: 7330434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycosis surveillance of compromised patients by means of the E-rosette-test (author's transl)].
    Seebacher C; Bässler E
    Mykosen; 1981 Nov; 24(11):668-76. PubMed ID: 6976511
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
    El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
    Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal formation of rosette (E and EAC) in Hodgkin's disease].
    Lenzini L; Rottoli L; Rottoli P
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1579-83. PubMed ID: 1085157
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of cell-mediated immunity in patients with Crohn's disease.
    Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
    Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rosette tests in lymphoproliferative diseases].
    Michlmayr G; Pathouli C; Falkensammer M; Huber C; Huber H; Braunsteiner H
    Schweiz Med Wochenschr; 1976 Jun; 106(23):794-9. PubMed ID: 792996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocyte membrane markers in lympho and immunoproliferative diseases (proceedings)].
    Del Giacco GS; Manconi PE; Fadda F; Grifoni V; Tognella S; Mantovani G; Leone AL
    Minerva Med; 1977 Oct; 68(50):3433-40. PubMed ID: 927718
    [No Abstract]   [Full Text] [Related]  

  • 14. Enkephalins--enhancement of active T-cell rosettes from lymphoma patients.
    Miller GC; Murgo AJ; Plotnikoff NP
    Clin Immunol Immunopathol; 1983 Mar; 26(3):446-51. PubMed ID: 6603310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Circulating T- and B-lymphocyte indices in chronic enteritis].
    Stenina MA; Cheredeev AN; Krymkina TN; Grigor'ian ON
    Ter Arkh; 1980; 52(2):92-5. PubMed ID: 6966431
    [No Abstract]   [Full Text] [Related]  

  • 17. Phytohemagglutinin-induced changes in cultured lymphocytes in the course of some lymphoproliferative and reticuloproliferative diseases. I. Blastic transformation.
    Rozynkowa D; Kowalewski J
    Pol Med J; 1970; 9(4):847-54. PubMed ID: 5273571
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of levamisole on E rosette inhibition by serum of malnourished children.
    Salimonu LS
    Biomed Pharmacother; 1983; 37(6):276-80. PubMed ID: 6200157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G; Huber C; Fink U; Falkensammer M; Huber H
    Schweiz Med Wochenschr; 1974 Jun; 104(23):815-20. PubMed ID: 4546217
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.